Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics股價上漲,因該公司發佈了Q2業績,收入超過預期,併發布了FY24營業收入指引高於預期。
Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics公佈的第二季度財務業績好於預期,併發布了高於預期的24財年收入指引,股價走高。